Yu Cheng Patients Health Care Services Act Article 4
The Yu-Cheng patients who must be reviewed and confirmed by the central competent authority according to Subparagraph 1, Paragraph 2 of the preceding article shall provide documentation of toxic exposure and application to the municipal or county (city) competent authority. This documentation is then transferred to the central competent authority for review.The documentation mentioned in the preceding paragraph shall be reviewed by a committee of experts invited by the central competent authority.The abnormal report of blood levels of polychlorinated biphenyls (PCBs) or polychlorinated dibenzofurans (PCDFs) concentrations issued by an analytical laboratory authorized by the central competent authority may be used as the supplementary documentation as mentioned in Subparagraph 1.The criteria for the evaluation of PCBs or PCDFs concentrations mentioned in the preceding paragraph shall be prescribed by the central competent authority.
中文原文 油症患者健康照護服務條例第4條
前條第二項第一款須經中央主管機關審查確認之油症患者，應檢具中毒暴露相關證明文件向直轄市、縣（市）主管機關申請，轉中央主管機關審查。
前項證明文件，由中央主管機關邀請專家學者成立委員會審查之。
經中央主管機關認可檢驗機構出具之血液多氯聯苯（PCBs）或多氯呋喃（PCDF）濃度異常報告，得作為第一項之補充證明文件。
前項報告之多氯聯苯及多氯呋喃血液濃度異常值，由中央主管機關定之。
前項證明文件，由中央主管機關邀請專家學者成立委員會審查之。
經中央主管機關認可檢驗機構出具之血液多氯聯苯（PCBs）或多氯呋喃（PCDF）濃度異常報告，得作為第一項之補充證明文件。
前項報告之多氯聯苯及多氯呋喃血液濃度異常值，由中央主管機關定之。